Cargando…
Exploring Rosiglitazone’s Potential to Treat Alzheimer’s Disease through the Modulation of Brain-Derived Neurotrophic Factor
SIMPLE SUMMARY: This review focuses on rosiglitazone, a medication used to treat diabetes. Rosiglitazone lowers blood sugar levels by helping the body use insulin more efficiently. Individuals with diabetes have a higher risk of developing Alzheimer’s disease, a complex memory-loss disorder affectin...
Autores principales: | Nelson, Mackayla L., Pfeifer, Julia A., Hickey, Jordan P., Collins, Andrila E., Kalisch, Bettina E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376118/ https://www.ncbi.nlm.nih.gov/pubmed/37508471 http://dx.doi.org/10.3390/biology12071042 |
Ejemplares similares
-
Sex Differences in the Level of Homocysteine in Alzheimer’s Disease and Parkinson’s Disease Patients: A Meta-Analysis
por: Nguyen, V. Phu, et al.
Publicado: (2023) -
Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease
por: Collins, Andrila E., et al.
Publicado: (2022) -
VANL-100 Attenuates Beta-Amyloid-Induced Toxicity in SH-SY5Y Cells
por: Collins, Andrila E., et al.
Publicado: (2022) -
Neurotrophic Factor-α1 prevents stress-induced depression through enhancement of neurogenesis and is activated by rosiglitazone
por: Cheng, Yong, et al.
Publicado: (2014) -
The effect of dietary supplementation on brain-derived neurotrophic factor and cognitive functioning in Alzheimer's dementia
por: Martin, Alicia, et al.
Publicado: (2017)